Triple Combination Nitazoxanide, Ribavirin, and Hydroxychloroquine results in the multiplicative reduction of in vitro SARS-CoV-2 viral replication
E. Lian, C. McAlister, G. Ramirez, D. N. Chernoff, G. Went, J. Hoopes, R. Perera
This study tests a triple drug combination for reducing SARS-CoV-2 replication in vitro, finding a significant multiplicative effect on virus yield and delayed cytopathic effects.
bioRxiv · Nov 25, 2020 · PreprintMicrobiology